Pharma looks for quantum leap in drug development
Quantum computing and biotech companies are testing whether next-generation computing technology could help them develop better drugs and cut the time and cost of finding new ones....
Quantum computing and biotech companies are testing whether next-generation computing technology could help them develop better drugs and cut the time and cost of finding new ones....
For the first time in nearly two decades, the University of Wisconsin-Madison’s medical school will have a new leader....
From GLP-1RA and HIV PrEP successes, to flops in DMD and Alzheimer’s, Clinical Trials Arena rounds up the biggest trial read outs of 2024....
One major way AI is set to revolutionize clinical trials is by automating patient recruitment, which is typically the most time-consuming part of a clinical trial....
More than 100 clinical trials put stem cells for regenerative medicine to the test. It’s a turning point for a field beset with ethical and political controversy....
UW Health’s new Eastpark Medical Center has seen an average of 1,000 patients a day in the month since it opened, an immediate wave of demand that reinforces the clinic’s goal of addressing a regional need, a top official says....
Four key predictions for the future of clinical trials, examining how these changes will revolutionize the speed, efficiency, and reliability of bringing life-saving treatments to market....
Potential clinical trial participants often must weigh the possible long-term benefits against immediate disruptions to their lives. ...
Engaging patients in clinical research has long been seen as important, yet it has been slow to evolve. For years, clinical research has largely been designed with the assumption that participants should conform to rigid protocols, often neglecting the voices of the very people who...
It’s widely agreed that clinical trial participants should reflect the populations of people who will ultimately be affected by the resulting treatments....